International Clinical Trial: Preloading Intravenous magnesium sulfate to reduce Vancomycin induced nephrotoxicity: An open - label, randomized controlled trial(MARVIN study)

Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (TCTR20251010004) titled 'Preloading Intravenous magnesium sulfate to reduce Vancomycin induced nephrotoxicity: An open - label, randomized controlled trial(MARVIN study)' on Oct. 10.

Study Type: Interventional

Study Design: Randomized

Primary Sponsor: N/A

Condition: Preventing Vancomycin-Induced Nephrotoxicity Vancomycin-Induced Nephrotoxicity,Magnesium Supplementation,Acute kidney injury Vancomycin-Induced Nephrotoxicity,Magnesium Supplementation,Acute kidney injury

Intervention: Group A (Magnesium group) Vancomycin plus Magnesium supplementation to maintain serum magnesium 2 to 3 mg/dl during therapy (Mg monitored q48h, dose adj...